NeuraWorx is a neurotechnology company focused on bioelectronic approaches to improving cerebral waste clearance as a therapeutic strategy for neurodegenerative disease prevention and treatment. The company operates within the neuromodulation domain, targeting vascular and fluid dynamics rather than direct neural signaling.

Its technology platform, described as Intelligent Cerebrovascular Pacing™, is a multimodal neuromodulation approach designed to enhance cerebrovascular vasomotion and glymphatic system activity. In preclinical studies, the system has demonstrated increases in cerebral artery pulsation and cerebrospinal fluid flow, key drivers of biomolecule clearance from brain tissue.

NeuraWorx’s work is positioned toward future clinical deployment for aging-related and neurodegenerative conditions, including Alzheimer’s disease. The company’s approach aligns with emerging interest in glymphatic and meningeal lymphatic systems as therapeutic targets, bridging vascular neuromodulation and brain health research.